Biolabs Health

April 2026. No name, no formula, no category position — a longevity ritual to invent end to end. We started where most brands finish: with the biology, and the decision to build everything else around it.

Ten clinically-dosed compounds, one daily ritual, twelve hallmarks of aging. We made the dose ledger the brand’s own language — every active named at its exact dose, never a proprietary blend, never a dusting. Precision became the identity, not a claim bolted onto it.

Naming, identity, the vessel in glass and brushed aluminium, the wardrobe that goes with it, and the digital flagship — one standard across a range built to grow from Longevity to Protein, Recovery, Focus and Energy. Formulated and third-party tested in Geneva, so the rigour is shown, not asserted.

Biolabs enters the fastest-moving corner of wellness: in 2025 healthy-aging supplements were the quickest-rising category on the market, and NMN — its signature compound — is the segment’s fastest riser. The brand is built to lead that wave, not follow it. Launching 01·01·2027.